• Hero Banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Buying or Selling a Practice
Hospital Design
Leadership & Personal Growth
Personnel Management
Practice Finances
Practice Operations
Technology
Wellbeing & Lifestyle
Continuing Education
Conferences
Live Conferences
Conference News
Conference Proceedings
Resources
CBD in Pets
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Silver Nanoparticles and Postsurgical Wound Treatment

April 29, 2017
JoAnna Pendergrass, DVM

Silver nanoparticles have demonstrated marked antibacterial activity against multi-drug resistant bacteria commonly found in infected postsurgical wounds in humans.

Using a leaf extract, researchers synthesized silver nanoparticles (Ag-NPs) that demonstrated marked antibacterial activity against multi-drug resistant bacteria commonly found in infected human postsurgical wounds, according to a study recently published in Microbial Pathogenesis. Study results suggest that nanoparticles created through environmentally friendly processes “have potential applications in the field of nanomedicine for the effective treatment of wound infection,” the researchers wrote.

Postsurgical wound infections affect 15% to 60% of surgical patients. These wounds are frequently nosocomial and can have serious financial and health consequences. The bacteria most commonly found in postsurgical wounds—Staphylococcus aureus, Pseudomonas aeruginosa, coagulase-negative staphylococci (CoNS)—demonstrate multi-drug resistance, making wound treatment difficult.

Ag-NPs have strong antimicrobial activity at low concentrations with minimal toxicity. Researchers have begun to explore “green,” chemical-free methods to synthesize Ag-NPs. One such method is the use of leaf extracts, such as that from the shrub Corchorus capsularis. C. capsularis has many clinical uses (laxative, appetite stimulant) and can act as a reducing and stabilizing agent for Ag-NP synthesis.

For the current study, researchers synthesized Ag-NPs from a C. capsularis leaf extract and used advanced imaging techniques to analyze the Ag-NPs’ size, morphology, and crystal structure. They also collected wound swab samples from patients with clinically evident postsurgical wound infections; swabs underwent testing to determine gram negativity or positivity. Researchers then performed a series of tests to evaluate the Ag-NPs’ antibacterial activity against the 3 bacterial isolates (S. aureus, P. aeruginosa, CoNS) as well as cytotoxicity.

Study Results

Advertisement

Ag-NP Structural Characteristics

Using UV-visible spectroscopy, researchers demonstrated Ag-NP stability for up to 1 month at room temperature. Transmission electron microscopy indicated that the Ag-NPs were elliptical and spheroidal; using a histogram, researchers calculated a mean Ag-NP size of 20.5 nm. Other imaging techniques, including X-ray diffraction, revealed the Ag-NPs’ highly crystalline structure with minimal crystal asymmetry.

Ag-NP Antibacterial Activity

Researchers performed a disk diffusion assay, which demonstrated that increased Ag-NP concentrations linearly increased diameters of the zones of inhibition for each of the bacterial isolates. Mean zone of inhibition diameters were generally similar among the isolates at the highest Ag-NP concentration used (60 µg/mL). Notably, Ag-NP activity was favorable to that of gentamicin.

Another assay was performed by treating about 100 colony-forming units (CFU) of bacterial isolates with increasing Ag-NP concentrations, up to 100 µg/mL. The number of CFUs dropped markedly with higher Ag-NP concentrations, particularly for S. aureus and CoNS. Researchers observed that reduction of CFU numbers was notable even at the lowest Ag-NP concentrations.

Bacterial growth kinetics were also measured. At 3-hour intervals up to 24 hours, bacterial growth decreased over time and with increasing Ag-NP concentration.

To explain this antibacterial activity, researchers described how Ag-NPs penetrate the bacterial cell wall and release silver ions, which generate reactive oxygen species; the reactive oxygen species likely play a major role in Ag-NP antibacterial activity, which includes disrupting both cell membrane integrity and important cellular functions, ultimately resulting in cell death.

Ag-NP Cytotoxicity

At a range of concentrations up to 200 µg/mL, Ag-NPs demonstrated minimal cytotoxicity in mouse embryo fibroblast cells. In fact, toxicity remained undetectable at each Ag-NP concentration until the last time point (72 hours), at which toxicity was detected at the 3 highest concentrations.

Conclusions

­Study results indicate the potential clinical usefulness of Ag-NP for treating postsurgical skin wounds infected with multi-drug resistant bacteria. In addition, the authors noted, Ag-NPs could be used to produce wound-healing bandages.

Dr. JoAnna Pendergrass received her Doctor of Veterinary Medicine degree from the Virginia-Maryland College of Veterinary Medicine. Following veterinary school, she completed a postdoctoral fellowship at Emory University’s Yerkes National Primate Research Center. Dr. Pendergrass is the founder and owner of JPen Communications, a medical communications company.


Advertisement

Latest News

Humanimal Trust joins World Federation for Animals

News wrap-up: This week’s headlines, plus Kansas State University College of Veterinary Medicine presents Temple Grandin, PhD, MS, with an honorary degree

Can our Pride panel answer these LGBTQ+ trivia questions?

Creating inclusive spaces for the LGBTQ+ community in vet med

View More Latest News
Advertisement